Asia Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.

Press releases published on October 5, 2026

Mulvihill Canadian Bank ETF Declares Monthly Distribution
Premium Global Income Split Fund Declares Monthly Distribution
Mulvihill Split Preferred Share ETF Declares Monthly Distribution
Mulvihill Premium Yield Declares Monthly Fund Distribution for Its ETF Class
iCell Gene Therapeutics Announces Upcoming Conference Presentations
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
DeFi Development Corp. to Host X Spaces Event: “August & September 2026 Recap & AMA”
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
OceanFirst Financial Corp. Schedules Third Quarter 2026 Earnings Conference Call
Deadline Alert: HDFC Bank Limited (HDB) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Deadline Alert: UWM Holdings Corporation (UWMC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
PesoRama Announces C$25 Million Bought Deal Public Offering
Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
WatchGuard Unveils Major Unified Security Platform® Innovations at IMPACT North America
Deadline Alert: Taboola.com Ltd. (TBLA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Deadline Alert: GoDaddy Inc. (GDDY) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Big Bear Gold Corp. Announces Change of Transfer Agent to Olympia Trust Company
Top Technology Executives Recognized at the 2026 BayAreaCIO ORBIE Awards 
FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Business Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.